Literature DB >> 24759710

Mechanical homogenization increases bacterial homogeneity in sputum.

Joshua R Stokell1, Ammad Khan1, Todd R Steck2.   

Abstract

Sputum obtained from patients with cystic fibrosis (CF) is highly viscous and often heterogeneous in bacterial distribution. Adding dithiothreitol (DTT) is the standard method for liquefaction prior to processing sputum for molecular detection assays. To determine if DTT treatment homogenizes the bacterial distribution within sputum, we measured the difference in mean total bacterial abundance and abundance of Burkholderia multivorans between aliquots of DTT-treated sputum samples with and without a mechanical homogenization (MH) step using a high-speed dispersing element. Additionally, we measured the effect of MH on bacterial abundance. We found a significant difference between the mean bacterial abundances in aliquots that were subjected to only DTT treatment and those of the aliquots which included an MH step (all bacteria, P = 0.04; B. multivorans, P = 0.05). There was no significant effect of MH on bacterial abundance in sputum. Although our results are from a single CF patient, they indicate that mechanical homogenization increases the homogeneity of bacteria in sputum.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24759710      PMCID: PMC4097738          DOI: 10.1128/JCM.00487-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set.

Authors:  Mangala A Nadkarni; F Elizabeth Martin; Nicholas A Jacques; Neil Hunter
Journal:  Microbiology       Date:  2002-01       Impact factor: 2.777

2.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

Authors:  Stephen A Bustin; Vladimir Benes; Jeremy A Garson; Jan Hellemans; Jim Huggett; Mikael Kubista; Reinhold Mueller; Tania Nolan; Michael W Pfaffl; Gregory L Shipley; Jo Vandesompele; Carl T Wittwer
Journal:  Clin Chem       Date:  2009-02-26       Impact factor: 8.327

3.  Assessment of sample handling practices on microbial activity in sputum samples from patients with cystic fibrosis.

Authors:  A Nelson; A De Soyza; S J Bourke; J D Perry; S P Cummings
Journal:  Lett Appl Microbiol       Date:  2010-06-20       Impact factor: 2.858

4.  Novel pan-genomic analysis approach in target selection for multiplex PCR identification and detection of Burkholderia pseudomallei, Burkholderia thailandensis, and Burkholderia cepacia complex species: a proof-of-concept study.

Authors:  Chi-Chun Ho; Candy C Y Lau; Paolo Martelli; San-Yuen Chan; Cindy W S Tse; Alan K L Wu; Kwok-Yung Yuen; Susanna K P Lau; Patrick C Y Woo
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

5.  Decade-long bacterial community dynamics in cystic fibrosis airways.

Authors:  Jiangchao Zhao; Patrick D Schloss; Linda M Kalikin; Lisa A Carmody; Bridget K Foster; Joseph F Petrosino; James D Cavalcoli; Donald R VanDevanter; Susan Murray; Jun Z Li; Vincent B Young; John J LiPuma
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

6.  Spatial distribution of microbial communities in the cystic fibrosis lung.

Authors:  Dana Willner; Matthew R Haynes; Mike Furlan; Robert Schmieder; Yan Wei Lim; Paul B Rainey; Forest Rohwer; Douglas Conrad
Journal:  ISME J       Date:  2011-07-28       Impact factor: 10.302

7.  Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis.

Authors:  Paul C Blainey; Carlos E Milla; David N Cornfield; Stephen R Quake
Journal:  Sci Transl Med       Date:  2012-09-26       Impact factor: 17.956

8.  Reducing bias in bacterial community analysis of lower respiratory infections.

Authors:  Geraint B Rogers; Leah Cuthbertson; Lucas R Hoffman; Peter A C Wing; Christopher Pope; Danny A P Hooftman; Andrew K Lilley; Anna Oliver; Mary P Carroll; Kenneth D Bruce; Christopher J van der Gast
Journal:  ISME J       Date:  2012-11-29       Impact factor: 10.302

9.  Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling.

Authors:  G B Rogers; C A Hart; J R Mason; M Hughes; M J Walshaw; K D Bruce
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

10.  The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.

Authors:  Anthony A Fodor; Erich R Klem; Deirdre F Gilpin; J Stuart Elborn; Richard C Boucher; Michael M Tunney; Matthew C Wolfgang
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

View more
  5 in total

Review 1.  Yersinia pestis: the Natural History of Plague.

Authors:  R Barbieri; M Signoli; D Chevé; C Costedoat; S Tzortzis; G Aboudharam; D Raoult; M Drancourt
Journal:  Clin Microbiol Rev       Date:  2020-12-09       Impact factor: 26.132

2.  Comparison of targeted metagenomics and IS-Pro methods for analysing the lung microbiome.

Authors:  T Goolam Mahomed; Rph Peters; Ghj Pretorius; A Goolam Mahomed; V Ueckermann; M M Kock; M M Ehlers
Journal:  BMC Microbiol       Date:  2021-08-18       Impact factor: 3.605

Review 3.  Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics.

Authors:  Christian E Demeure; Olivier Dussurget; Guillem Mas Fiol; Anne-Sophie Le Guern; Cyril Savin; Javier Pizarro-Cerdá
Journal:  Genes Immun       Date:  2019-04-03       Impact factor: 2.676

4.  Emergence of a Distinct Picobirnavirus Genotype Circulating in Patients Hospitalized with Acute Respiratory Illness.

Authors:  Michael G Berg; Kenn Forberg; Lester J Perez; Ka-Cheung Luk; Todd V Meyer; Gavin A Cloherty
Journal:  Viruses       Date:  2021-12-17       Impact factor: 5.048

5.  Lung microbiome of stable and exacerbated COPD patients in Tshwane, South Africa.

Authors:  T Goolam Mahomed; R P H Peters; M Allam; A Ismail; S Mtshali; A Goolam Mahomed; V Ueckermann; M M Kock; M M Ehlers
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.